CN1193775C - Rheumatoid disease treating capsule - Google Patents

Rheumatoid disease treating capsule Download PDF

Info

Publication number
CN1193775C
CN1193775C CNB001267892A CN00126789A CN1193775C CN 1193775 C CN1193775 C CN 1193775C CN B001267892 A CNB001267892 A CN B001267892A CN 00126789 A CN00126789 A CN 00126789A CN 1193775 C CN1193775 C CN 1193775C
Authority
CN
China
Prior art keywords
radix
herba
medicine
ankylosing spondylitis
rheumatoid arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB001267892A
Other languages
Chinese (zh)
Other versions
CN1362068A (en
Inventor
李毅
李鹏
李海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001267892A priority Critical patent/CN1193775C/en
Publication of CN1362068A publication Critical patent/CN1362068A/en
Application granted granted Critical
Publication of CN1193775C publication Critical patent/CN1193775C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses medicinal rheumatoid capsules for treating rheumatoid arthritis and ankylosing spondylitis, which uses a low dose of tripterygium wilfordii as a main medicine, and 27 Chinese herbal medicines such as ginseng, astragalus roots, epimedium, aconite roots, rehmannia roots, herba sarcandrae inj, etc. are intensively used, extracted, decocted in liquid, concentrated into an ointment, and are mixed with 14 Chinese herbal medicines such as scorpions, centipedes, etc. so as to be made into the capsules. The clinical verification of tens of thousands of patients of the rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus and a dryness syndrome shows that the medicine can improve microcirculation, enhance the blood supply of spines, joints and the peripheral tissue thereof, improve nutritional status, accelerate the regeneration capability and the cell viability of the tissue, promote the inflammation absorption of the spines, the joints and the peripheral tissue thereof, and reduce the accumulation of pain producing substance. The method has the advantages of definite therapeutic effect, safety and few side effects, and the capsules are a medicine treating both manifestation and root cause of a disease.

Description

The rheumatoid medicine of treatment rheumatoid arthritis, ankylosing spondylitis
The present invention is a kind of Chinese patent medicine for the treatment of rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus.
Rheumatoid arthritis, ankylosing spondylitis, all by the natural endowment deficiency, the day after tomorrow overstrain, intemperate sexual intercourse, it is multiple to lose blood puerperal, caused by liver and kidney deficiency, the affection of exogenous wind-cold damp, the resistance of QI and blood numbness becomes that to give birth to blood stasis expectorant turbid, stops up in stagnate joint, the ridge.Doctor and patient, in order to palliate the agonizing sufferings, the life-time service hormone has been covered the state of an illness, has affected treatment adversely, also produced the hormonelike blood stasis, made pathological changes local blood circulation obstacle, caused QI and blood unfavorable, muscles and bones mistake is supported, clonic spasm of the muscle bone pine, ankylosis, deformity, amyotrophy, paralysis is maimed.At present, adopt nonsteroidal antiinflammatory drug both at home and abroad, as: indometacin, ibuprofen, naproxen, diclofenac, meloxicam and golden preparation, antimalarial, methotrexate, the hormone medicine treatment, but eventually because of rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus, disease is special, obstinate, cause the maimed paralysis of patient, become can be not dead cancer.
Purpose of the present invention is exactly in order to provide a kind of treatment rheumatoid arthritis, ankylosing spondylitis, the Chinese patent medicine of lupus erythematosus.
The object of the present invention is achieved like this, and the rheumatoid medicine of treatment rheumatoid arthritis, ankylosing spondylitis is to be made by the following weight proportion raw material.
One, extracts partly
Make black river 15 Radix Aconiti Kusnezoffii Preparatas, 15 Rhizoma Arisaematis (processed), 15 Herba Asaris 15
Fructus Psoraleae 25 Radix Aconiti Lateralis Preparatas 25 Rhizoma Drynariae 25 Radix Astragali 100
Herba Epimedii 50 Radix Angelicae Sinensis 25 Radixs Stephaniae Tetrandrae 50 Rhizoma Atractylodis Macrocephalaes 25
Radix Salviae Miltiorrhizae 50 Radix Rehmanniae 10 Radix Clematidis 50 Poria 25
Radix Gentianae Macrophyllae 25 Flos Lonicerae 25 Herba Aristolochiae Mollissimaes 25 Cortex Phellodendris 25
Polyporus 25 Herba Pileae Scriptaes 120 Herba Ephedraes 10 crust halberds 25
Rhizoma Curculiginis 25 Cortex Cinnamomis 5 Semen Sinapis Albaes 10
Two, fines is partly:
System Pheretima 15 Olibanums 10 Myrrhas 10 Agkistrodons 10
Nidus Vespae 15 Scorpios 15 Bombyx Batryticatus 15 Zaocyss 15
Ground beetle 15 Scolopendras 10 Radix Notoginseng 10 Radix Ginsengs 25
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum (0.1%) 6.
Prescription of the present invention is with liver and kidney tonifying, cooperates dredge the meridian passage, improve immunologic function, search the product that pick heavy cold arthralgia due to blood stasis, rule together to scheme specimen, reuse Radix Ginseng, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis in the side, benefiting qi and nourishing blood is regulated immunologic function, Fructus Psoraleae, Rhizoma Drynariae, crust halberd, Rhizoma Curculiginis, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Herba Epimedii, nourishing the liver and kidney, warming the meridian is supporing yang with cold expelling, insects medicines such as Semen Sinapis Albae, Rhizoma Arisaematis, ground beetle, Scorpio, Scolopendra, Pheretima, Radix Aconiti Kusnezoffii, Agkistrodon, search and pick the meridians expectorant stasis of blood, the priming sick institute that goes directly; Radix Aconiti Preparata, Herba Ephedrae, Radix Stephaniae Tetrandrae, Herba Asari, Radix Gentianae Macrophyllae, the wind dispelling collateral dredging, the damp eliminating reducing swelling and alleviating pain, Radix Tripterygii Wilfordii has multiple pharmacological effect such as significant antiinflammatory, immunosuppressant, the treatment rheumatoid arthritis, curative effect is sure, but side effect is outstanding, the present invention adopt low dose of Radix Tripterygii Wilfordii extractum (for usual amounts 1/6) be principal agent, obviously lowered poison and paid effect.All medicines share, and microcirculation improvement is promoted the blood supply of spinal column, joint and surrounding tissue thereof, improves nutritional status, quickens tissue regeneration ability and cell viability, promote spinal column, joint and inflammation absorption on every side thereof, algogenic substance is piled up reduced.Thereby remove rheumatoid, the stiff pain of ankylosing spondylitis symptom, promote functional rehabilitation.Be mainly used in rheumatoid arthritis, ankylosing spondylitis, the treatment of lupus erythematosus, our determined curative effect, the safety effect of paying is lacked.Through clinical verification, patient more than 98% is eliminated or palliate the agonizing sufferings.
Embodiments of the invention are described in detail in detail below.
1. the prescription of the rheumatoid medicine of treatment rheumatoid arthritis, ankylosing spondylitis is made up of the two large divisions, is specially:
One, extracts partly
Make black river 15g Radix Aconiti Kusnezoffii Preparata 15g Rhizoma Arisaematis (processed) 15g Herba Asari 15g
Fructus Psoraleae 25g Radix Aconiti Lateralis Preparata 25g Rhizoma Drynariae 25g Radix Astragali 100g
Herba Epimedii 50g Radix Angelicae Sinensis 25g Radix Stephaniae Tetrandrae 50g Rhizoma Atractylodis Macrocephalae 25g
Radix Salviae Miltiorrhizae 50g Radix Rehmanniae 10g Radix Clematidis 50g volt Siberian cocklebur 25g
Radix Gentianae Macrophyllae 25g Flos Lonicerae 25g Herba Aristolochiae Mollissimae 25g Cortex Phellodendri 25g
Polyporus 25g Herba Pileae Scriptae 120g Herba Ephedrae 10g crust halberd 25g
Rhizoma Curculiginis 25g Cortex Cinnamomi 5g Semen Sinapis Albae 10g
Two, fines is partly:
System Pheretima 15g Olibanum 10g Myrrha 10g Agkistrodon 10g
Nidus Vespae 15g Scorpio 15g Bombyx Batryticatus 15g Zaocys 15g
Ground beetle 15g Scolopendra 10g Radix Notoginseng 10g Radix Ginseng 25g
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum (0.1%) 6g.
2. treat the preparation method of the rheumatoid medicine of rheumatoid arthritis, ankylosing spondylitis:
(1) Semen Strychni (processed) powder: after getting qualified Semen Strychni and soaking 7 days with urine of baby boys, stir-baking with sand to color is sepia, pulverizes, and sieves, and is standby.
(2) preparation of Radix Tripterygii Wilfordii extractum: with Radix Tripterygii Wilfordii concoct qualified after, place decoction pot, add water and cross powder, decoct secondary, collecting decoction filters, and is condensed into cream, it is that 1.30,80 ℃ of crushed after being dried are sieved that heat is surveyed density (d), standby.
(3) preparation fines part medicated powder: the fines that infusion is qualified medical material partly, crushing screening, standby.
(4) medicated powder is partly extracted in preparation: will extract medicinal material processing partly qualified after, place decoction pot, add water and cross powder, decoct secondary, liquid before merging filters, and is condensed into cream, heat survey density (d) is that 1.30,80 ℃ of crushed after being dried are sieved, and is standby.
(5) mix: will extract medicated powder partly, abundant mixing, fines medicated powder partly, the method that increases progressively by equivalent adds, and after sieving, incapsulates promptly.
Every capsules medicine weighs 0.3 ± 5%, by the capsule for rheumatoid disease that above amount is made, can obey three months, and three months is a course of treatment.Two weeks has promptly got tangible curative effect.Usage and dosage is one day three times, each 2~3, promptly obeys after meal.

Claims (1)

1. rheumatoid medicine for the treatment of rheumatoid arthritis, ankylosing spondylitis is characterized in that it is made by the following weight proportion raw material, and raw material is made up of two parts:
One, extracts partly
Make black river 15 Radix Aconiti Kusnezoffii Preparatas, 15 Rhizoma Arisaematis (processed), 15 Herba Asaris 15
Fructus Psoraleae 25 Radix Aconiti Lateralis Preparatas 25 Rhizoma Drynariae 25 Radix Astragali 100
Herba Epimedii 50 Radix Angelicae Sinensis 25 Radixs Stephaniae Tetrandrae 50 Rhizoma Atractylodis Macrocephalaes 25
Radix Salviae Miltiorrhizae 50 Radix Rehmanniae 10 Radix Clematidis 50 Poria 25
Radix Gentianae Macrophyllae 25 Flos Lonicerae 25 Herba Aristolochiae Mollissimaes 25 Cortex Phellodendris 25
Polyporus 25 Herba Pileae Scriptaes 120 Herba Ephedraes 10 crust halberds 25
Rhizoma Curculiginis 25 Cortex Cinnamomis 5 Semen Sinapis Albaes 10
Two, fines is partly:
System Pheretima 15 Olibanums 10 Myrrhas 10 Agkistrodons 10
Nidus Vespae 15 Scorpios 15 Bombyx Batryticatus 15 Zaocyss 15
Ground beetle 15 Scolopendras 10 Radix Notoginseng 10 Radix Ginsengs 25
Semen Strychni (processed) powder 150 Radix Tripterygii Wilfordii extractum 6
Wherein, Radix Tripterygii Wilfordii extractum is made as follows: with Radix Tripterygii Wilfordii concoct qualified after, place decoction pot, add water and cross powder, decoct secondary, collecting decoction filters, and is condensed into cream, it is that 1.30,80 ℃ of crushed after being dried are sieved that heat is surveyed density d, standby.
CNB001267892A 2000-12-30 2000-12-30 Rheumatoid disease treating capsule Expired - Lifetime CN1193775C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001267892A CN1193775C (en) 2000-12-30 2000-12-30 Rheumatoid disease treating capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001267892A CN1193775C (en) 2000-12-30 2000-12-30 Rheumatoid disease treating capsule

Publications (2)

Publication Number Publication Date
CN1362068A CN1362068A (en) 2002-08-07
CN1193775C true CN1193775C (en) 2005-03-23

Family

ID=4592072

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001267892A Expired - Lifetime CN1193775C (en) 2000-12-30 2000-12-30 Rheumatoid disease treating capsule

Country Status (1)

Country Link
CN (1) CN1193775C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015650B (en) * 2006-12-04 2010-05-12 尹政德 Zhuifengtouguhuoluo pills (capsule) and its preparation process

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1330354C (en) * 2004-01-05 2007-08-08 刘少华 Malus spectabilis snake lice pill
CN100457137C (en) * 2004-03-05 2009-02-04 广东药学院 Polylactic acid microglobule Chinese medicine compound for mula used for treating bone arthritis and its preparation method
CN1308020C (en) * 2004-12-13 2007-04-04 刘文奇 Chinese medicinal composition for treating tinea
CN1300176C (en) * 2005-06-29 2007-02-14 中国药科大学 New saponin and its derivative, its preparation method and its use in medicine
CN1330328C (en) * 2005-06-29 2007-08-08 中国药科大学 Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof
CN101301394B (en) * 2008-06-27 2011-01-26 樊玉仁 Medicament for treating rheumatoid disease
CN102186489B (en) * 2008-10-07 2013-10-02 特拉维夫大学拉玛特有限公司 Use of cinnamon bark extract for treating amyloid-associated diseases
CN101485747B (en) * 2009-03-04 2011-07-27 陈新华 Chinese medicinal composition for treating degenerative pathologic changes of knee joint
CN101502571B (en) * 2009-03-16 2012-07-04 上海师范大学 Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof
CN102716252B (en) * 2011-06-20 2014-11-19 王长锋 Medicine for oral use for treating rheumatism and rheumatoid ankylosing spondylitis
CN102488818B (en) * 2011-12-30 2013-06-05 伍启友 Pharmaceutical composition for treating rheumatism and rheumatoid arthritis
CN102600404B (en) * 2012-03-28 2013-11-13 刘玉柱 Traditional Chinese medicine for treating undifferentiated spondyloarthropathy
CN102872387B (en) * 2012-10-11 2014-06-18 王慧艳 Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens
CN105687917A (en) * 2016-04-25 2016-06-22 沙宗跃 Oral solution for treating arthritis
CN109200156A (en) * 2018-11-12 2019-01-15 徐扬 A kind of traditional Chinese herbal decoction for treating deficiency of vital energy cold dampness accumulation pattern ankylosing spondylitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015650B (en) * 2006-12-04 2010-05-12 尹政德 Zhuifengtouguhuoluo pills (capsule) and its preparation process

Also Published As

Publication number Publication date
CN1362068A (en) 2002-08-07

Similar Documents

Publication Publication Date Title
CN1186043C (en) Exterior-applied medicine for treating osteopathy
CN1193775C (en) Rheumatoid disease treating capsule
CN101066303B (en) Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN101085223A (en) Medicine for treating rheumatism and rheumatoid disease
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN101690768B (en) Vein and artery relieving pills for impediment of sinew
CN1994453B (en) Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis
CN1317021C (en) Chinese medicinal formulation for stopping pain for removing Bi
CN101040949B (en) Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application
CN1079029C (en) Medical capsule for treating bone rheumatism and preparing process
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1907480A (en) Decoction preparation for treating rheumatoid arthritis and its preparation process
CN101317958B (en) Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof
CN100402065C (en) Capsule for treating gout and preparation process thereof
CN1223886A (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN101264187A (en) Medicinal composition for treating chronic prostatitis and prostatic hyperplasia
CN1181879C (en) Analgestic plaster
CN108310217A (en) Zhuanggu medicinal liquor and production method
CN102743531B (en) Drug for treating cervical or lumbar diseases and preparation method thereof
CN1054986C (en) Chinese medicine pill for treating rheumatoid disease
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea
CN1235605C (en) Medicinal composition for treating gall
CN101966304A (en) Medicament for freeing network vessels and activating blood and preparation method thereof
CN102038834A (en) Traditional Chinese medicine preparation for preventing and treating cancers

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20050323

CX01 Expiry of patent term
DD01 Delivery of document by public notice

Addressee: Li Yi

Document name: Notice of expiration of patent right

DD01 Delivery of document by public notice